Belgium
10
2012-05-24
10
2013-05-07
These are the the leading inventors for applications assigned to UCB Pharma S.A.:
UCB Pharma S.A. based in , BE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
DNA encoding antibody molecules which bind human IL-17
#2 | 2012-03-01 ✅ Patent 8,785,628 granted on 2014-07-22Triazine derivatives as kinase inhibitors
#3 | 2010-10-21 ✅ Patent 8,303,953 granted on 2012-11-06Antibody molecules which bind IL-17A and IL-17F
#4 | 2010-10-07 ✅ Patent 8,614,295 granted on 2013-12-24Antibody molecules having specificity for human OX40
#5 | 2010-06-24 ✅ Patent 8,465,744 granted on 2013-06-18Method of treating inflammation by administering human IL-1B antibodies
#6 | 2010-04-15 ✅ Patent 8,507,654 granted on 2013-08-13Altered antibodies
#7 | 2009-07-07 ✅ Patent 7,557,130 granted on 2009-07-07Bicyclic heteroaromatic alanines
#8 | 2009-05-07 ✅ Patent 8,231,875 granted on 2012-07-31Neutralising antibody molecules having specificity for human IL-17
#9 | 2008-12-11 ✅ Patent 8,378,073 granted on 2013-02-19Process for attaching effector molecules to proteins
#10 | 2006-05-18 ✅ Patent 7,419,659 granted on 2008-09-02Expression control using variable intergenic sequences
408524 ⎘